tykhr
sign in
free sign up
Kyverna Therapeutics, Inc. Common Stock
Biotechnology
Healthcare
KYTX
43.22 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
6.70
52 week high
7.38
high
6.88
52 week low
0.00
low
6.14
growth
-1.25 %
previous Close
6.52
P/E ratio
market cap
131 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
5.83 %
eps surprise
4.90 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top